| FWWMX | RTDCX | FWWMX / RTDCX | |
| Total Expense Ratio | 0.31 | 1.64 | 19% |
| Annual Report Gross Expense Ratio | 0.31 | 1.64 | 19% |
| Fund Existence | 6 years | 8 years | - |
| Gain YTD | 3.857 | 11.019 | 35% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 219B | 287M | 76,307% |
| Annual Yield % from dividends | 1.44 | 0.23 | 618% |
| Returns for 1 year | 5.76 | -9.58 | -60% |
| Returns for 3 years | 29.16 | -8.29 | -352% |
| Returns for 5 years | 30.81 | -13.46 | -229% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PAYR | 54.62 | 0.42 | +0.78% |
| Federated Hermes Enhanced Income ETF | |||
| HIPS | 11.60 | 0.01 | +0.09% |
| GraniteShares HIPS US High Income ETF | |||
| BIS | 13.22 | N/A | N/A |
| ProShares UltraShort Nasdaq Biotech | |||
| FNGS | 75.12 | -0.38 | -0.50% |
| MicroSectors™ FANG+™ ETN | |||
| DFEM | 38.65 | -1.28 | -3.21% |
| Dimensional Emerging Markets Cr Eq 2 ETF | |||